OK. One last column on the whole “why is my medicine so expensive” thing, and then I am done. Promise.
It has come to my attention that one of my Healio | OSN pieces was “borrowed” to support a manufacturer’s cash-pay strategy for its dry eye disease (DED) medication. I am flattered, of course, and also grateful for the opportunity this provides to shed some light on the whole “opt out” of insurance thing when it comes to prescription medications.
In a nutshell, a patient who wishes to fill a (Read more...)